Heart rhythm experts from around the world will gather in Boston to share groundbreaking research and learn of innovations in the field of cardiac electrophysiology.
Stuttgart, Germany – 4 May, 2015 – New clinical data will be presented at the 36th Heart Rhythm Society Annual Scientific Sessions, in Boston from May 13 – 16, 2015.
Five abstracts which relate to the role of CCM in the treatment of chronic heart failure will be presented at the HRS Annual Scientific Sessions. The clinical data which will be presented adds to the knowledge about the use of the CCM therapy in different settings and supplements the growing body of evidence regarding the safety of CCM therapy and its effects on quality of life and exercise capacity in heart failure patients.
Information about the presentations are listed below:
Oral Abstract Presentation
Cardiac Contractility Modulation with the OPTIMIZER System in Patients with Symptomatic Heart Failure despite Optimal Medical Therapy and Cardiac Resynchronization Therapy
May 14, 2015, 1:30 – 1:45 PM
Poster Presentation
The Subcutaneous Implantable Cardioverter-Defibrillator – First Single-Center Experience with Concomitant Implantable Pulse Generators
May 14, 2015, 2:00 – 5:00 PM
Poster Presentation
Long-Term Impact of Cardiac Contractility Modulation on QRS Duration
May 14, 2015, 2:00 – 5:00 PM
Poster Presentation
A Randomized Comparison of 5 versus 12 Hours per Day of Cardiac Contractility Modulation Treatment for Heart Failure Patients
May 15, 2015, 2:00 – 5:00 PM
Oral Abstract Presentation
Efficacy and Survival in Patients with Cardiac Contractility Modulation: Long-Term Single Center Experience in 81 Patients
May 15, 2015, 2:15 – 2:30 PM
About the Optimizer and CCM Therapy
The Optimizer™ IVs device delivers the CCM therapy and it has been successfully launched in Europe and is available in cardiology centers in various countries. The CCM therapy has been implanted in over 2000 patients to date and is the only device therapy available for patients with narrow QRS complex. Impulse Dynamics has completed a vast number of clinical studies, including several randomized controlled trials. The results have been published in over 60 publications in leading medical journals. The Optimizer system is limited to Investigational use only in the United States.
About Impulse Dynamics
Impulse Dynamics N.V. is focused on the development of electrical therapies for the treatment of chronic heart failure. As a global leader in cardiac medical innovation, Impulse Dynamics has operations in the US, Europe, Asia and Australia. For more information please visit www.impulse-dynamics.com
Impulse Dynamics Germany GmbH
Breitwiesenstraße 19
70565 Stuttgart
Tel.: +49 711 220456-0
Fax: +49 711 220456-19
Recent Comments